The Bulletin
Times Advertising


.

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

  • Written by The Bulletin

SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc.

Read more: Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South...

hacklink hack forum hacklink film izle hacklink testsahabetslot gacoronwinRocket Playivermectin tabletiptv satın aliptv satın alcasibomTaraftarium24jojobetmarsbahis 1084casibomagb99galabetbetofficebetofficedeneme bonusuMeritbet girişMeritbetNon Gamstop Sitesroyalbet girişdinamobetmarsbahismeritkingdizipaljojobetjojobetpokerklasjojobetelexbet